DOCSLIB.ORG

HUMAN MITOCHONDRIAL TRANSFER Rnas: ROLE of PATHOGENIC MUTATION in DISEASE

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HUMAN MITOCHONDRIAL TRANSFER Rnas: ROLE of PATHOGENIC MUTATION in DISEASE INVITED REVIEW ABSTRACT: The human mitochondrial genome encodes 13 proteins. All are subunits of the respiratory chain complexes involved in energy metab- olism. These proteins are translated by a set of 22 mitochondrial transfer RNAs (tRNAs) that are required for codon reading. Human mitochondrial tRNA genes are hotspots for pathogenic mutations and have attracted interest over the last two decades with the rapid discovery of point mutations associated with a vast array of neuromuscular disorders and diverse clinical phenotypes. In this review, we use a scoring system to determine the pathogenicity of the mutations and summarize the current knowledge of structure–function relationships of these mutant tRNAs. We also provide readers with an overview of a large variety of mechanisms by which muta- tions may affect the mitochondrial translation machinery and cause disease. Muscle Nerve 37: 150–171, 2008 HUMAN MITOCHONDRIAL TRANSFER RNAs: ROLE OF PATHOGENIC MUTATION IN DISEASE FERNANDO SCAGLIA, MD, and LEE-JUN C. WONG, PhD Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA Accepted 17 September 2007 Normal mitochondrial function depends on both tion and termination factors, ribosomal proteins, the expression of the mitochondrial genome and the and enzymes involved in maturation and posttran- expression of at least 1,300 nuclear genes whose scriptional modification of tRNAs are nuclear en- products are imported into the mitochondria. Hu- coded. However, the complete set of 22 tRNAs and man mitochondrial DNA (mtDNA) is a 16,569-kb two major rRNAs are of mitochondrial origin. circular, double-stranded molecule. It encodes 13 of The adaptation of the bacterial ancestors of mito- more than 80 polypeptide subunits of the mitochon- chondria to the new environment of eukaryotic cells drial respiratory chain complexes and contains 24 brought the advantage of ATP production via the pro- additional genes required for mitochondrial protein cess of oxidative phosphorylation. However, the pres- biosynthesis. These include two rRNA genes and 22 ence in mitochondria of an electron transport chain tRNA genes, one for each of 20 amino acids, and two that continuously reduces oxygen to build up an elec- each for tRNALeu (UUR and CUN codons) and trochemical gradient required for ATP synthesis has a tRNASer (UCN and AGY codons).140 All partners of potentially deleterious side effect for these eukaryotic the mitochondrial protein synthetic machinery such cells. This side effect consists of the constant genera- as aminoacyl-tRNA synthetases, initiation, elonga- tion of reactive oxygen species (ROS). Due to the continuous function of the electron transport chain, the minimal electron leakage is sufficient to make mi- Available for Category 1 CME credit through the AANEM at www.aanem.org. tochondrial O2.- generation the major cellular source Abbreviations: A, adenine; ATP, adenosine triphosphate; C, cytosine; COX, of ROS in most tissues. MtDNA is located in the mito- cytochrome c oxidase; CPEO, chronic progressive external ophthalmoplegia; chondrial matrix and its close proximity to the respi- DHU, dihydrouridine; G, guanine; mtDNA, mitochondrial deoxyribonucleic acid; MELAS, mitochondrial encephalomyopathy, lactic acidosis, and stroke- ratory chain complexes embedded in the inner mem- like episodes; MERRF, myoclonic epilepsy with ragged-red fibers; NO, nitric oxide; PEO, progressive external ophthalmoplegia; RC, respiratory chain; brane renders it susceptible to oxidative stress, causing ROS, reactive oxygen species; rRNA, ribosomal ribonucleic acid; SNHL, sen- its high mutation rate (10–17-fold higher rate of mu- sorineural hearing loss; T, thymine; tRNA, transfer ribonucleic acid; U, uracil 1,122 Key words: cardiomyopathy; chronic progressive external ophthalmoplegia; tations than the nuclear genome). diabetes mellitus; encephalomyopathy; focal segmental glomerulosclerosis; Since the first description of pathogenic muta- human mitochondrial tRNA genes; mitochondrial cytopathies; mitochondrial myopathy; myoclonic epilepsy; pathogenic mutations; ragged-red fibers; ret- tions in the mitochondrial genome, over 200 disease- initis pigmentosa; sensorineural hearing loss; stroke-like episodes correlated point mutations and rearrangements Correspondence to: L. J. C. Wong; e-mail: [email protected] have been found in association with a variety of © 2007 Wiley Periodicals, Inc. 88 Published online 9 November 2007 in Wiley InterScience (www.interscience. mitochondrial cytopathies. More than half of these wiley.com). DOI 10.1002/mus.20917 mutations have been located in tRNA genes that 150 Human Mitochondrial tRNAs MUSCLE & NERVE February 2008 constitute ϳ9% of the entire mitochondrial ge- Most of the observed mtDNA changes represent neu- nome.91 Thus, mitochondrial tRNA genes are hot- tral polymorphisms and have been used to track spots for mitochondrial pathogenesis and contribute human migrations.70 The large prevalence of varia- in a disproportionate way to the etiology of disorders tions in tRNA genes calls for the elucidation of their caused by mitochondrial DNA mutations, which is pathogenicity. In addition, clinical misattribution of conceivable due to their central role in mitochon- pathogenicity is an important issue due to the con- drial protein synthesis. In comparison, a little less sequences for genetic counseling that is provided to than half of the mitochondrial mutations affect pro- individuals and families with mitochondrial disease. tein coding genes, which comprises 68% of the en- Benign variants can be mistaken as bona fide patho- tire mitochondrial genome.42 genic mutations when found in one or a limited To achieve their goal of carrying amino acids for number of individuals, especially if present in the protein synthesis, these tRNA molecules have to un- heteroplasmic state, which has been regarded as di- dergo different steps of processing and modifica- rect evidence for pathogenicity. tion, and interact with many protein factors.128 Dis- A set of rules had to be established to confirm the ease-related mutations could potentially affect the pathogenic nature of novel mtDNA mutations. Di primary, secondary, and tertiary structures of a given Mauro and Schon35 have previously described the mitochondrial tRNA. Misfolding and instability of canonical pathogenic criteria for mtDNA point mu- the mutant tRNA result in increased degradation tations. These rules specified that the mutation and ultimately lead to decreased steady-state levels of should (1) be absent in healthy subjects, (2) alter an a mitochondrial tRNA. In addition, the efficiency of evolutionary conserved residue, (3) be heteroplas- the aminoacylation process will be particularly sen- mic and segregate with disease, (4) be such that the sitive to point mutations because the enzymes in- degree of mutant heteroplasmy correlates with clin- volved recognize a specific structure of a tRNA.196 ical severity and cell pathology as documented by There are still many unanswered questions re- single-fiber polymerase chain reaction (PCR), and garding the phenotypic effect of these mutations. (5) cause defects of mitochondrial protein synthesis Perhaps one of the most intriguing is the incredible and respiratory chain deficiencies in single or mul- diversity of clinical phenotypes associated with mito- tiple affected tissues of patients and demonstrable in chondrial tRNA mutations. This is a phenomenon cybrid cell lines. Cybrid cell lines are generated by that has been observed even among individuals har- transferring mitochondria isolated from patients boring the same mutation. Several factors including harboring pathogenic mutations into cultured hu- the percentage of heteroplasmy, the different tissues man cells treated with ethidium bromide to deplete affected with the mutation, the position of the their mitochondrial DNA.81 mutation within the structure of the tRNA gene, the However, some pathogenic mtDNA mutations efficiency in the utilization of different codons fail to meet these established canonical criteria. In for the same amino acid, and the different amino particular, the homoplasmic mutations often do not acid composition among the mitochondrial DNA- demonstrate the required segregation with either encoded protein subunits may account for this vari- biochemical deficiency or clinical disease. It is now ability. In addition, nuclear genes, different mito- known that homoplasmic mitochondrial tRNA mu- chondrial genetic backgrounds, and environmental tations can be pathogenic, as demonstrated with factors may also exert a modifier effect. several mutations in the tRNASer(UCN) gene,72 the The aim of this review is to focus on the assess- 1624 CϾT mutation in the tRNAVal that caused mul- ment of pathogenic mitochondrial tRNA mutations, tiple neonatal deaths and Leigh syndrome in the the pathogenic mechanism of disease of known and offspring of a homoplasmic and mildly affected well-established mutations, the description of new woman,100 the 4291 TϾC in the tRNAIle gene asso- pathogenic mutations, and the elucidation of their ciated with hypertension and dyslipidemia,195 the clinical significance. 4300 AϾG in the tRNAIle gene responsible for ma- ternally inherited cardiomyopathy in two families,173 CANONICAL CRITERIA FOR ASSESSING and the 5693 TϾC change in the mitochondrial PATHOGENICITY OF MITOCHONDRIAL tRNA tRNAAsn gene that caused encephalomyopathy.27 In MUTATIONS addition, true pathogenic mutations may escape MtDNA alterations
Load more

Recommended publications
  • Mt-Atp8 Gene in the Conplastic Mouse Strain C57BL/6J-Mtfvb/NJ on the Mitochondrial Function and Consequent Alterations to Metabolic and Immunological Phenotypes
    From the Lübeck Institute of Experimental Dermatology of the University of Lübeck Director: Prof. Dr. Saleh M. Ibrahim Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD Dissertation for Fulfillment of Requirements for the Doctoral Degree of the University of Lübeck from the Department of Natural Sciences Submitted by Paul Schilf from Rostock Lübeck, 2016 First referee: Prof. Dr. Saleh M. Ibrahim Second referee: Prof. Dr. Stephan Anemüller Chairman: Prof. Dr. Rainer Duden Date of oral examination: 30.03.2017 Approved for printing: Lübeck, 06.04.2017 Ich versichere, dass ich die Dissertation ohne fremde Hilfe angefertigt und keine anderen als die angegebenen Hilfsmittel verwendet habe. Weder vorher noch gleichzeitig habe ich andernorts einen Zulassungsantrag gestellt oder diese Dissertation vorgelegt. ABSTRACT Mitochondria are critical in the regulation of cellular metabolism and influence signaling processes and inflammatory responses. Mitochondrial DNA mutations and mitochondrial dysfunction are known to cause a wide range of pathological conditions and are associated with various immune diseases. The findings in this work describe the effect of a mutation in the mitochondrially encoded mt-Atp8 gene in the conplastic mouse strain C57BL/6J-mtFVB/NJ on the mitochondrial function and consequent alterations to metabolic and immunological phenotypes. This work provides insights into the mutation-induced cellular adaptations that influence the inflammatory milieu and shape pathological processes, in particular focusing on autoimmune bullous diseases, which have recently been reported to be associated with mtDNA polymorphisms in the human MT-ATP8 gene. The mt-Atp8 mutation diminishes the assembly of the ATP synthase complex into multimers and decreases mitochondrial respiration, affects generation of reactive oxygen species thus leading to a shift in the metabolic balance and reduction in the energy state of the cell as indicated by the ratio ATP to ADP.
    [Show full text]
  • Mitochondrial Complex III Deficiency Associated with a Homozygous Mutation in UQCRQ
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT Mitochondrial Complex III Deficiency Associated with a Homozygous Mutation in UQCRQ Ortal Barel,1 Zamir Shorer,2 Hagit Flusser,2 Rivka Ofir,1 Ginat Narkis,1 Gal Finer,1 Hanah Shalev,2 Ahmad Nasasra,2 Ann Saada,3 and Ohad S. Birk1,4,* A consanguineous Israeli Bedouin kindred presented with an autosomal-recessive nonlethal phenotype of severe psychomotor retarda- tion and extrapyramidal signs, dystonia, athetosis and ataxia, mild axial hypotonia, and marked global dementia with defects in verbal and expressive communication skills. Metabolic workup was normal except for mildly elevated blood lactate levels. Brain magnetic resonance imaging (MRI) showed increased density in the putamen, with decreased density and size of the caudate and lentiform nuclei. Reduced activity specifically of mitochondrial complex III and variable decrease in complex I activity were evident in muscle biopsies. Homozygosity of affected individuals to UQCRB and to BCSIL, previously associated with isolated complex III deficiency, was ruled out. Genome-wide linkage analysis identified a homozygosity locus of approximately 9 cM on chromosome 5q31 that was further narrowed down to 2.14 cM, harboring 30 genes (logarithm of the odds [LOD] score 8.82 at q ¼ 0). All 30 genes were sequenced, revealing a single missense (p.Ser45Phe) mutation in UQCRQ (encoding ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5 kDa), one of the ten nuclear
    [Show full text]
  • ARTICLES Functional Mitochondrial Heterogeneity in Heteroplasmic
    0031-3998/00/4802-0143 PEDIATRIC RESEARCH Vol. 48, No. 2, 2000 Copyright © 2000 International Pediatric Research Foundation, Inc. Printed in U.S.A. ARTICLES Functional Mitochondrial Heterogeneity in Heteroplasmic Cells Carrying the Mitochondrial DNA Mutation Associated with the MELAS Syndrome (Mitochondrial Encephalopathy, Lactic Acidosis, and Strokelike Episodes) ANNETTE BAKKER, CYRILLE BARTHE´ LE´ MY, PAULE FRACHON, DANIELLE CHATEAU, DAMIEN STERNBERG, JEAN PIERRE MAZAT, AND ANNE LOMBE` S INSERM UR523, Institut de Myologie, 75651 Paris, France [A.B., C.B., P.F., D.C., A.L.]; Biochimie B, Hoˆpital de La Salpeˆtrie`re, 75651 Paris, France [D.S.]; and Universite´ de Bordeaux II, INSERM E99–29, 33076 Bordeaux cedex, France [J.P.M.] ABSTRACT Most mitochondrial DNA (mtDNA) alterations associated wild-type mtDNA, transfer RNA, or protein. Mitochondria in with human disorders are heteroplasmic, i.e. mutant mtDNA these heteroplasmic cells cannot, therefore, be considered a molecules coexist with normal ones within the cell. We ad- single functional unit. (Pediatr Res 48: 143–150, 2000) dressed the possibility of intermitochondrial exchanges through histologic analyses of cybrid clones with increasing proportion of the MELAS (A3243G) mtDNA transfer RNA point mutation. Abbreviations MtDNA-dependent cytochrome c oxidase activity and protein MELAS, mitochondrial myopathy, encephalopathy, lactic composition as well as mitochondrial membrane potential ap- acidosis, and strokelike episodes peared heterogeneous in individual cells from clonal heteroplas-
    [Show full text]
  • Biomarkers of Mitotoxicity After Acute Liver Injury: Further Insights Into the Interpretation of Glutamate Dehydrogenase
    Journal of Clinical and Translational Research 10.18053/Jctres/07.202101.005 MINI REVIEW Biomarkers of mitotoxicity after acute liver injury: further insights into the interpretation of glutamate dehydrogenase Mitchell R. McGill1,2* and Hartmut Jaeschke3 1. Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, AR, USA, 72205 2. Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR, USA, 72205 3. Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS, USA, 66160 *Corresponding author Mitchell R. McGill, PhD Department of Environmental Health Sciences & Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR Tel: +1 501-526-6696 Email: [email protected] Article information: Received: November 03, 2020 Revised: December 09, 2020 Accepted: December 10, 2020 Journal of Clinical and Translational Research 10.18053/Jctres/07.202101.005 ABSTRACT Background: Acetaminophen (APAP) is a popular analgesic, but overdose causes acute liver injury and sometimes death. Decades of research have revealed that mitochondrial damage is central in the mechanisms of toxicity in rodents, but we know much less about the role of mitochondria in humans. Due to the challenge of procuring liver tissue from APAP overdose patients, non-invasive mechanistic biomarkers are necessary to translate the mechanisms of APAP hepatotoxicity from rodents to patients. It was recently proposed that the mitochondrial matrix enzyme glutamate dehydrogenase (GLDH) can be measured in circulation as a biomarker of mitochondrial damage.
    [Show full text]
  • Stouthamer1973
    Antonie van Leeuwenhoek 39 (1973) 545-565 545 A theoretical study on the amount of ATP required for synthesis of microbial cell material A. H. STOUTHAMER Biological Laboratory, Free University, de Boelelaan 1087, Amsterdam, the Netherlands STOUTHAMER, A.H. 1973. A theoretical study on the amount of ATP required for synthesis of microbial cell material. Antonie van Leeuwenhoek 39: 545-565. The amount of ATP required for the formation of microbial cells growing under various conditions was calculated. It was assumed that the chemical com­ position of the cell was the same under all these conditions. The analysis of the chemical composition of microbial cells of Morowitz ( 1968) was taken as a base. It was assumed that 4 moles of ATP are required for the incorporation of one mole of amino acid into protein. The amount of ATP required on account of the instability and frequent regeneration of messenger RNA was calculated from data in the literature pertaining to the relative rates of synthesis of the various classes of RNA molecules in the cell. An estimate is given of the amount of ATP required for transport processes. For this purpose it was assumed that 0.5 mole of ATP is necessary for the uptake of 1 g-ion of potassium or ammo­ nium, and 1 mole of ATP for the uptake of 1 mole of phosphate, amino acid, acetate, malate etc. The results of the calculations show that from preformed monomers (glucose, amino acids and nucleic acid bases) 31.9 g cells can be formed per g-mole of ATP when acetyl-CoA is formed from glucose.
    [Show full text]
  • Tyramine and Amyloid Beta 42: a Toxic Synergy
    biomedicines Article Tyramine and Amyloid Beta 42: A Toxic Synergy Sudip Dhakal and Ian Macreadie * School of Science, RMIT University, Bundoora, VIC 3083, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-3-9925-6627 Received: 5 May 2020; Accepted: 27 May 2020; Published: 30 May 2020 Abstract: Implicated in various diseases including Parkinson’s disease, Huntington’s disease, migraines, schizophrenia and increased blood pressure, tyramine plays a crucial role as a neurotransmitter in the synaptic cleft by reducing serotonergic and dopaminergic signaling through a trace amine-associated receptor (TAAR1). There appear to be no studies investigating a connection of tyramine to Alzheimer’s disease. This study aimed to examine whether tyramine could be involved in AD pathology by using Saccharomyces cerevisiae expressing Aβ42. S. cerevisiae cells producing native Aβ42 were treated with different concentrations of tyramine, and the production of reactive oxygen species (ROS) was evaluated using flow cytometric cell analysis. There was dose-dependent ROS generation in wild-type yeast cells with tyramine. In yeast producing Aβ42, ROS levels generated were significantly higher than in controls, suggesting a synergistic toxicity of Aβ42 and tyramine. The addition of exogenous reduced glutathione (GSH) was found to rescue the cells with increased ROS, indicating depletion of intracellular GSH due to tyramine and Aβ42. Additionally, tyramine inhibited the respiratory growth of yeast cells producing GFP-Aβ42, while there was no growth inhibition when cells were producing GFP. Tyramine was also demonstrated to cause increased mitochondrial DNA damage, resulting in the formation of petite mutants that lack respiratory function.
    [Show full text]
  • Progressive Increase in Mtdna 3243A>G Heteroplasmy Causes
    Progressive increase in mtDNA 3243A>G PNAS PLUS heteroplasmy causes abrupt transcriptional reprogramming Martin Picarda, Jiangwen Zhangb, Saege Hancockc, Olga Derbenevaa, Ryan Golhard, Pawel Golike, Sean O’Hearnf, Shawn Levyg, Prasanth Potluria, Maria Lvovaa, Antonio Davilaa, Chun Shi Lina, Juan Carlos Perinh, Eric F. Rappaporth, Hakon Hakonarsonc, Ian A. Trouncei, Vincent Procaccioj, and Douglas C. Wallacea,1 aCenter for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; bSchool of Biological Sciences, The University of Hong Kong, Hong Kong, People’s Republic of China; cTrovagene, San Diego, CA 92130; dCenter for Applied Genomics, Division of Genetics, Department of Pediatrics, and hNucleic Acid/Protein Research Core Facility, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; eInstitute of Genetics and Biotechnology, Warsaw University, 00-927, Warsaw, Poland; fMorton Mower Central Research Laboratory, Sinai Hospital of Baltimore, Baltimore, MD 21215; gGenomics Sevices Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806; iCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; and jDepartment of Biochemistry and Genetics, National Center for Neurodegenerative and Mitochondrial Diseases, Centre Hospitalier Universitaire d’Angers, 49933 Angers, France Contributed by Douglas C. Wallace, August 1, 2014 (sent for review May
    [Show full text]
  • Characterization of Two Cdnas Encoding Mitochondrial Lipoamide Dehydrogenase from Arabidopsis Isabelle Lutziger Iowa State University
    Botany Publication and Papers Botany 10-2001 Characterization of Two cDNAs Encoding Mitochondrial Lipoamide Dehydrogenase from Arabidopsis Isabelle Lutziger Iowa State University David J. Oliver Iowa State University, [email protected] Follow this and additional works at: http://lib.dr.iastate.edu/bot_pubs Part of the Botany Commons Recommended Citation Lutziger, Isabelle and Oliver, David J., "Characterization of Two cDNAs Encoding Mitochondrial Lipoamide Dehydrogenase from Arabidopsis" (2001). Botany Publication and Papers. 1. http://lib.dr.iastate.edu/bot_pubs/1 This Article is brought to you for free and open access by the Botany at Iowa State University Digital Repository. It has been accepted for inclusion in Botany Publication and Papers by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Characterization of Two cDNAs Encoding Mitochondrial Lipoamide Dehydrogenase from Arabidopsis Abstract In contrast to peas (Pisum sativum), where mitochondrial lipoamide dehydrogenase is encoded by a single gene and shared between the α-ketoacid dehydrogenase complexes and the Gly decarboxylase complex, Arabidopsis has two genes encoding for two mitochondrial lipoamide dehydrogenases. Northern-blot analysis revealed different levels of RNA expression for the two genes in different organs; mtLPD1 had higher RNA levels in green leaves compared with the much lower level in roots. The mRNA formtLPD2 shows the inverse pattern. The other organs examined showed nearly equal RNA expressions for both genes. Analysis of etiolated seedlings transferred to light showed a strong induction of RNA expression for mtLPD1 but only a moderate induction of mtLPD2. Based on the organ and light-dependent expression patterns, we hypothesize thatmtLPD1encodes the protein most often associated with the Gly decarboxylase complex, and mtLPD2 encodes the protein incorporated into α-ketoacid dehydrogenase complexes.
    [Show full text]
  • Shared Sulfur Mobilization Routes for Trna Thiolation and Molybdenum Cofactor Biosynthesis in Prokaryotes and Eukaryotes
    biomolecules Review Shared Sulfur Mobilization Routes for tRNA Thiolation and Molybdenum Cofactor Biosynthesis in Prokaryotes and Eukaryotes Silke Leimkühler *, Martin Bühning and Lena Beilschmidt Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, 14476 Potsdam, Germany; [email protected] (M.B.); [email protected] (L.B.) * Correspondence: [email protected]; Tel.: +49-331-977-5603 Academic Editor: Valérie de Crécy-Lagard Received: 8 December 2016; Accepted: 9 January 2017; Published: 14 January 2017 Abstract: Modifications of transfer RNA (tRNA) have been shown to play critical roles in the biogenesis, metabolism, structural stability and function of RNA molecules, and the specific modifications of nucleobases with sulfur atoms in tRNA are present in pro- and eukaryotes. Here, especially the thiomodifications xm5s2U at the wobble position 34 in tRNAs for Lys, Gln and Glu, were suggested to have an important role during the translation process by ensuring accurate deciphering of the genetic code and by stabilization of the tRNA structure. The trafficking and delivery of sulfur nucleosides is a complex process carried out by sulfur relay systems involving numerous proteins, which not only deliver sulfur to the specific tRNAs but also to other sulfur-containing molecules including iron–sulfur clusters, thiamin, biotin, lipoic acid and molybdopterin (MPT). Among the biosynthesis of these sulfur-containing molecules, the biosynthesis of the molybdenum cofactor (Moco) and the synthesis of thio-modified tRNAs in particular show a surprising link by sharing protein components for sulfur mobilization in pro- and eukaryotes. Keywords: tRNA; molybdenum cofactor; persulfide; thiocarboxylate; thionucleosides; sulfurtransferase; L-cysteine desulfurase 1.
    [Show full text]
  • Complete Sequence and Gene Organization of the Mitochondrial Genome of the Land Snail Albinuria Cornlea
    Copyright 0 1995 by the Genetics Society of America Complete Sequence and Gene Organization of the Mitochondrial Genome of the Land Snail Albinuria cornlea Evi Hatzoglou, George C. Rodakis and Rena Lecanidou Department of Biochemistry, Cell and Molecular Biology, and Genetics, University of Athens, Panepistimiopolis, Athens 157 01, Greece Manuscript receivedJanuary 31, 1995 Accepted for publication May 15, 1995 ABSTRACT The complete sequence (14,130 bp) of the mitochondrial DNA (mtDNA) of the land snail Ahinaria coerulea was determined. It contains 13 protein, two rRNA and 22 tRNA genes. Twenty-four of these genes are encoded by one and 13 genes by the other strand. The gene arrangement shares almost no similarities with that of two other molluscs for which the complete gene content and arrangement are known, the bivalve Mytilus edulis and the chiton Kathanna tunicata; the protein and rRNA gene order is similar to that of another terrestrial gastropod, Cepaeu nemoralis. Unusual features include the following: (1) the absence of lengthy noncoding regions (there are only 141 intergenic nucleotides interspersed at different gene borders, the longest intergenic sequence being 42 nucleotides), (2) the presence of several overlapping genes (mostlytRNAs), (3) the presence of tRNA-like structures and other stem and loop structures within genes. An RNA editing system acting on tRNAs must necessarily be invoked for posttranscriptional extension of the overlapping tRNAs. Due to these features, and also because of the small size of its genes (e.g.,it contains the smallest rRNA genes among the known coelomates), it is one of the most compact mitochondrial genomes known to date.
    [Show full text]
  • Molecular Basis of Dihydrouridine Formation on Trna
    Molecular basis of dihydrouridine formation on tRNA Futao Yua1, Yoshikazu Tanakab,c1, Keitaro Yamashitaa, Takeo Suzukid, Akiyoshi Nakamurac, Nagisa Hiranoc, Tsutomu Suzukid, Min Yaoa,c, and Isao Tanakaa,c,2 aGraduate School of Life Sciences, Hokkaido University, Sapporo 060-0810, Japan; bCreative Research Institution “Sousei,” Hokkaido University, Sapporo 001-0021, Japan; cFaculty of Advanced Life Sciences, Hokkaido University, Sapporo 060-0810, Japan; and dDepartment of Chemistry and Biotechnology, School of Engineering, University of Tokyo, Tokyo 113-8656, Japan Edited by Dieter Söll, Yale University, New Haven, CT, and approved October 3, 2011 (received for review July 28, 2011) Dihydrouridine (D) is a highly conserved modified base found Similarly, the site specificity and nonredundant catalytic func- in tRNAs from all domains of life. Dihydrouridine synthase (Dus) tions were also confirmed in three Dus from E. coli (YjbN, YhdG, catalyzes the D formation of tRNA through reduction of uracil base and YohI) (8). The crystal structure of Dus from Thermotoga with flavin mononucleotide (FMN) as a cofactor. Here, we report maritima has been reported (9), and mutation analysis of Dus the crystal structures of Thermus thermophilus Dus (TthDus), which from E. coli revealed important residues for dihydrouridine is responsible for D formation at positions 20 and 20a, in complex formation (10). One of the most remarkable biochemical features with tRNA and with a short fragment of tRNA (D-loop). Dus inter- of Dus is that other modifications of tRNA are required for the acts extensively with the D-arm and recognizes the elbow region enzymatic activity (11). However, the details of the reaction, composed of the kissing loop interaction between T- and D-loops in including the tRNA recognition mechanism and its catalysis of tRNA, pulling U20 into the catalytic center for reduction.
    [Show full text]
  • Protection Against Apoptosis by Monoamine Oxidase a Inhibitors
    View metadata,FEBS 20082 citation and similar papers at core.ac.uk FEBS Letters 426 (1998)brought to 155^159 you by CORE provided by Elsevier - Publisher Connector Protection against apoptosis by monoamine oxidase A inhibitors W. Malornia;*, A.M. Giammariolia, P. Matarresea, P. Pietrangelib, E. Agostinellib, A. Ciacciob, E. Grassillic, B. Mondovi'b aDepartment of Ultrastructures, Istituto Superiore di Sanitaé, Viale Regina Elena 299, 00161 Rome, Italy bDepartment of Biochemical Sciences and CNR Center of Molecular Biology, University of Rome `La Sapienza', Rome, Italy cDepartment of General Pathology, University of Modena, Modena, Italy Received 27 February 1998 mitochondrial membrane potential or apoptosis. Analytical Abstract Several lines of evidence have been accumulating indicating that an important role may be played by mitochondrial cytology analyses revealed that maintenance of the mitochon- homeostasis in the initiation phase, the first stage of apoptosis. drial homeostasis by pargyline and clorgyline is associated This work describes the results obtained by using different with a partial hindering of the apoptotic process. inhibitors of monoamine oxidases (MAO), i.e. pargyline, clorgyline and deprenyl, on mitochondrial integrity and apopto- 2. Materials and methods sis. Both pargyline and clorgyline are capable of protecting cells from apoptosis induced by serum starvation while deprenyl is 2.1. Cell cultures ineffective. These data represent the first demonstration that Human melanoma cells (M14) were grown in monolayer in modi- MAO-A inhibitors may protect cells from apoptosis through a ¢ed RPMI 1640 medium supplemented with 10% heat-inactivated mechanism involving the maintenance of mitochondrial homeo- fetal calf serum (FCS), 1 mM sodium pyruvate, 1% non-essential stasis.
    [Show full text]